Enhanced Computed Tomography or Magnetic Resonance Imaging: A Choice between Contrast Medium-Induced Nephropathy and Nephrogenic Systemic Fibrosis?

By Thomsen H. S.   Marckmann P.   Logager V. B.  

Acta Radiologica, Vol. 48, Iss. 6, 2007-01 ,pp. : 593-596

Blackwell Publishing

Access to resources Recommend Favorite

Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT - A pooled analysis of two randomized trials

By Thomsen Henrik  

European Radiology, Vol. 19, Iss. 4, 2009-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite

The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)

By Hayakawa Katsumi   Tanikake Masato   Kirishima Toshihiko   Yoshinami Naomi   Shintani Hiroyuki   Yamamoto Eiji   Morimoto Taisuke  

European Radiology, Vol. 24, Iss. 5, 2014-05 ,pp. : 1105-1111

Springer Publishing Company

Access to resources Recommend Favorite

Contrast-Induced Nephropathy: The Wheel Has Turned 360 Degrees

By Thomsen H. S.   Morcos S. K.   Barrett B. J.  

Acta Radiologica, Vol. 49, Iss. 6, 2008-01 ,pp. : 646-657

Blackwell Publishing

Access to resources Recommend Favorite

Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!

By Nyman Ulf  

European Radiology, Vol. 18, Iss. 9, 2008-09 ,pp. : 2013-2014

Springer Publishing Company

Access to resources Recommend Favorite